Gastroparesis trials in Poland

1 trial · From EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A phase 1 multi-centre, randomized, single-blind, steady-state study to evaluate pharmacokinetics, pharmacodynamics, safety and tolerability after multiple-dose administration of three different doses of naronapride in patients with moderate idiopathic or diabetic gastroparesis compared to healthy subjects

  Where

  Jozefow

  Age

  18 years and over

  People

  60 worldwide

  Run by

  Dr. Falk Pharma GmbH

  See details and how to join2024-516197-30-00